Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth

Cochrane Database of Systematic Reviews

Volumn 2021, Issue 2, 2020, Pages

  McGoldrick, Emma ^a   Stewart, Fiona ^b   Parker, Roses ^c   Dalziel, Stuart R ^d,e  

^a LIVERPOOL WOMEN'S NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e STARSHIP CHILDREN S HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID DERIVATIVE; GLUCOSE; HYDROCORTISONE; INSULIN; LUNG SURFACTANT; PLACEBO; BETAMETHASONE; CORTICOSTEROID; DEXAMETHASONE;

ACADEMIC ACHIEVEMENT; AIR LEAK SYNDROME; APGAR SCORE; ARTIFICIAL VENTILATION; BEHAVIOR DISORDER; BIRTH LENGTH; BIRTH WEIGHT; BODY HEIGHT; BODY WEIGHT; BRAIN HEMORRHAGE; CEREBRAL PALSY; CHILDHOOD MORTALITY; CHORIOAMNIONITIS; CHRONIC LUNG DISEASE; CLINICAL OUTCOME; COMORBIDITY; CONTINUOUS POSITIVE AIRWAY PRESSURE; DATA ANALYSIS; DISEASE SEVERITY; DRUG EFFECT; ENDOMETRITIS; FETUS DEATH; FETUS LUNG MATURATION; FETUS MORTALITY; FEVER; GLUCOSE INTOLERANCE; HEAD CIRCUMFERENCE; HIGH RISK PREGNANCY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOPHYSIS ADRENAL SYSTEM; INFORMATION PROCESSING; LEARNING DISORDER; LUNG DYSPLASIA; LUNG FUNCTION; MATERNAL DEATH; MATERNAL MORBIDITY; MATERNAL MORTALITY; MENTAL DISEASE; MULTIPLE PREGNANCY; NECROTIZING ENTEROCOLITIS; NEONATAL INTENSIVE CARE UNIT; NEWBORN DEATH; NEWBORN INFECTION; NEWBORN MORBIDITY; NEWBORN MORTALITY; OXYGEN THERAPY; PERINATAL DEATH; PERINATAL PERIOD; PREGNANT WOMAN; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRENATAL PERIOD; PUBERTY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY DISTRESS SYNDROME; REVIEW; SKINFOLD THICKNESS; SMALL FOR DATE INFANT; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; BRAIN VENTRICLE HEMORRHAGE; DEVELOPMENTAL DISORDER; EMBRYOLOGY; FEMALE; FETUS MATURITY; LUNG; META ANALYSIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PREGNANCY; PREMATURITY; PRENATAL CARE; PROCEDURES; STATISTICAL BIAS;

ADRENAL CORTEX HORMONES; BETAMETHASONE; BIAS; CEREBRAL INTRAVENTRICULAR HEMORRHAGE; DEVELOPMENTAL DISABILITIES; DEXAMETHASONE; FEMALE; FETAL ORGAN MATURITY; HUMANS; HYDROCORTISONE; INFANT, NEWBORN; LUNG; MATERNAL DEATH; PERINATAL DEATH; PREGNANCY; PREMATURE BIRTH; PRENATAL CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 85099076368     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004454.pub4     Document Type: Review

References (207)

1. Amorim MM, Santos LC, Faundes A. Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. American Journal of Obstetrics and Gynecology 1999;180(5):1283-8. x-wiley/crsRef/3154829
2. Attawattanakul N, Tansupswatdikul P. Effects of antenatal dexamethasone on respiratory distress in late preterm infant: a randomized controlled trial. Thai Journal of Obstetrics and Gynaecology 2015;23:25-33. x-wiley/crsRef/3154831
3. Balci O, Ozdemir S, Mahmoud AS, Acar A, Colakoglu MC. The effect of antenatal steroids on fetal lung maturation between the 34th and 36th week of pregnancy. Gynecologic and Obstetric Investigation 2010;70(2):95-9. x-wiley/crsRef/3154833
4. Block MF, Kling OR, Crosby WM. Antenatal glucocorticoid therapy for the prevention of respiratory distress syndrome in the premature infant. Obstetrics & Gynecology 1977;50:186-90. x-wiley/crsRef/3154835
5. Bauer CR, Morrison JC, Poole WK, Korones SB, Boehm JJ, Rigatto H, et al. A decreased incidence of necrotizing enterocolitis after prenatal glucocorticoid therapy. Pediatrics 1984;73:682-8. x-wiley/crsRef/3154843
6. Burkett G, Bauer CR, Morrison JC, Curet LB. Effect of prenatal dexamethasone administration on the prevention of respiratory distress syndrome in twin pregnancies. Journal of Perinatology 1986;6:304-8. x-wiley/crsRef/3154844
7. Collaborative Group on Antenatal Steroid Therapy. Amniotic fluid phospholipids after maternal administration of dexamethasone. American Journal of Obstetrics and Gynecology 1983;145:484-90. x-wiley/crsRef/3154845
8. Collaborative Group on Antenatal Steroid Therapy. Effect of antenatal dexamethasone administration in the infant: long term follow-up. Journal of Pediatrics 1984;105:259-67. x-wiley/crsRef/3154846
9. Collaborative Group on Antenatal Steroid Therapy. Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology 1981;141:276-87. x-wiley/crsRef/3154847
10. Curet LB, Rao AV, Zachman RD, Morrison J, Burkett G, Poole K, et al. Maternal smoking and respiratory distress syndrome. American Journal of Obstetrics and Gynecology 1983;147:446-50. x-wiley/crsRef/3154848
11. Haning RV, Curet LB, Poole K, Boehnlein LM, Kuzma DL, Meier SM. Effects of fetal sex and dexamethasone on preterm maternal serum concentrations of human chorionic gonadotropin, progesterone, estrone, estradiol, and estriol. American Journal of Obstetrics and Gynecology 1989;161:1549-53. x-wiley/crsRef/3154849
12. Wiebicke W, Poynter A, Chernick V. Normal lung growth following antenatal dexamethasone treatment for respiratory distress syndrome. Pediatric Pulmonology 1988;5:27-30. x-wiley/crsRef/3154850
13. Zachman RD, Bauer CR, Boehm J, Korones SB, Rigatto H, Rao AV. Effect of antenatal dexamethasone on neonatal leukocyte count. Journal of Perinatology 1988;8:111-3. x-wiley/crsRef/3154851
14. Zachman RD. The NIH multicenter study and miscellaneous clinical trials of antenatal corticosteroid administration. In: Farrell PM, editors(s). Lung Development: Biological and Clinical Perspectives. Vol. II. London & New York: Academic Press, 1982:275-96. x-wiley/crsRef/3154852
15. Pattinson RC, Funk M, Makin JD, Ficki H. The effect of dexamethasone on the immune system of women with preterm premature rupture of membranes: a randomised controlled trial. In: 15th Conference on Priorities in Perinatal Care in Southern Africa; 1996 March 5-8; Goudini Spa, South Africa. 1996. x-wiley/crsRef/3154854
16. Pattinson RC, Makin JD, Funk M, Delport SD, Macdonald AP, Norman K. The use of dexamethasone in women with preterm premature rupture of membranes: a multicentre double blind, placebo controlled randomised trial. South African Medical Journal 1999;89(8):865-70. x-wiley/crsRef/3154855
17. Pattinson RC. A meta-analysis of the use of corticosteroids in pregnancies complicated by preterm premature rupture of membranes. South African Medical Journal 1999;89(8):870-3. x-wiley/crsRef/3154856
18. The DEXIPROM Study Group. The use of dexamethasone in women with preterm premature rupture of membranes: a multicentre placebo controlled randomised controlled trial. In: 16th Conference on Priorities in Perinatal Care; 1997; South Africa. 1997:32-4. x-wiley/crsRef/3154857
19. Fekih M, Chaieb A, Sboui H, Denguezli W, Hidar S, Khairi H. Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study [Apport de la corticotherapie antenatale dans la prevention de la maladie des membranes hyalines chez le premature. Etude prospective randomisee]. Tunisie Medicale 2002;80(5):260-5. x-wiley/crsRef/3154861
20. Donnai P. UK multicentre trial of betamethasone for the prevention of respiratory distress syndrome. In: Proceedings of the 6th European Congress of Perinatal Medicine; 1978 Aug 29-Sept 1; Vienna, Austria. 1978:Abstract no: 81. x-wiley/crsRef/3154863
21. Gamsu HR, Mullinger BM, Donnai P, Dash CH. Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants: report of a UK multicentre trial. British Journal of Obstetrics and Gynaecology 1989;96:401-10. x-wiley/crsRef/3154864
22. Garite TJ, Rumney PJ, Briggs GG, Harding JA, Nageotte MP, Towers CV, et al. A randomized placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24-28 weeks gestation. American Journal of Obstetrics and Gynecology 1992;166:646-51. x-wiley/crsRef/3154866
23. Garite TJ, Rumney PJ, Briggs GG. A randomized, placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24-28 weeks gestation. Surgery, Gynecology and Obstetrics 1993;176:37. x-wiley/crsRef/3154867
24. Battarbee Ashley N. 41: fetal metabolic biomarkers after late preterm betamethasone and their association with neonatal hypoglycemia. American Journal of Obstetrics and Gynecology 2020;222(1):S35-S36. [CENTRAL: CN-02074433] x-wiley/crsRef/15907524 [EMBASE: 2004455290]
25. Bicocca MJ, Chen H-Y, Blackwell S, Sibai B, Mfmu N. 457: does prepregnancy weight or maternal BMI at betamethasone administration impact late preterm respiratory morbidity? American Journal of Obstetrics and Gynecology 2019;220(1):S306-S307. [CENTRAL: CN-01758135] x-wiley/crsRef/15907525 [EMBASE: 2001405365]
26. Carpenter J, Jablonski K, Koncinsky J, Varner M, Joss-Moore L. Antenatal steroids do not affect splicing or DNA methylation of the glucocorticoid receptor gene in cord blood T-cells. Reproductive Sciences (Thousand Oaks, Calif.) 2017;24(Suppl 1):258A. [CENTRAL: CN-01363475] x-wiley/crsRef/15907526 [EMBASE: 615322896]
27. Doty MS, Chen H-Y, Chauhan SP, Sibai BM. 464: time interval from betamethasone to delivery among women at risk for late preterm delivery. American Journal of Obstetrics and Gynecology 2019;220(1):S310-1. [CENTRAL: CN-01710941] x-wiley/crsRef/15907527 [EMBASE: 2001405276]
28. Gyamfi-Bannerman C, Thom EA, Blackwell SC, Tita AT, Reddy UM, Saade GR, et al. Antenatal betamethasone for women at risk for late preterm delivery. New England Journal of Medicine 2016;374(14):1311-20. x-wiley/crsRef/15907528
29. Gyamfi-Bannerman C, Zupancic JA, Sandoval G, Grobman WA, Blackwell SC, Tita AT, et al. Cost-effectiveness of antenatal corticosteroid therapy vs no therapy in women at risk of late preterm delivery: a secondary analysis of a randomized clinical trial. JAMA Pediatrics 2019;173(5):462-8. [CENTRAL: CN-01916423] x-wiley/crsRef/15907529 [EMBASE: 626717642] [PMID: 30855640]
30. Gyamfi-Bannerman C. Antenatal late preterm steroids (ALPS): a randomized trial to reduce neonatal respiratory morbidity. American Journal of Obstetrics and Gynecology 2016;214(1 Suppl):S2. x-wiley/crsRef/15907530
31. Gyamfi-Bannerman C. Respiratory morbidity after betamethasone (BMZ) treatment in infants of women at risk for late preterm delivery (LPD). American Journal of Obstetrics and Gynecology 2018;218(1 Suppl 1):S353. [CENTRAL: CN-01450832] x-wiley/crsRef/15907531 [EMBASE: 620309716]
32. Gyamfi-Bannerman C. Respiratory morbidity in pregnancies at risk for late preterm delivery in relation to cord blood concentrations of betamethasone and cortisol. Reproductive Sciences (thousand Oaks, Calif.) 2016;23(Suppl 1):274A. x-wiley/crsRef/15907532 [EMBASE: 72226697]
33. NCT01222247. Antenatal late preterm steroids (ALPS): a randomized placebo-controlled trial. clinicaltrials.gov/ct2/show/NCT01222247 (Date first received: 14 October 2010). x-wiley/crsRef/15907533
34. Purisch S, Handal-Orefice R, Ananth CV, Gyamfi-Bannerman C. Effect of BMI on neonatal respiratory outcomes in women at risk for late preterm birth. American Journal of Obstetrics and Gynecology. Conference: 38th Annual Meeting of the Society for Maternal-fetal Medicine: the Pregnancy Meeting. United States 2018;218(1 Suppl 1):S393-S394. [CENTRAL: CN-01450813] x-wiley/crsRef/15907534 [EMBASE: 620309949]
35. Viteri OA, Doty MS, Alrais MA, Sibai BM. 471: intended administration of antenatal late preterm steroids: is a single dose enough? American Journal of Obstetrics and Gynecology 2019;220(1):S315. [CENTRAL: CN-01710606] x-wiley/crsRef/15907535 [EMBASE: 2001405752]
36. Werner EF, Romano ME, Rouse DJ, Sandoval G, Gyamfi-Bannerman C, Blackwell SC, et al. Association of gestational diabetes mellitus with neonatal respiratory morbidity. Obstetrics and Gynecology 2019;133(2):349-53. [CENTRAL: CN-01788495] x-wiley/crsRef/15907536 [EMBASE: 626098249] [PMID: 30633135]
37. Eronen M, Kari A, Pesonen E, Hallman M. The effect of antenatal dexamethasone administration on the fetal and neonatal ductus arteriosus: a randomised double-blind study. American Journal of Diseases of Children 1993;147:187-92. x-wiley/crsRef/3154874
38. Kari MA, Akino T, Hallman M. Prenatal dexamethasone (DEX) treatment before preterm delivery and rescue therapy of exogenous surfactant- surfactant components and surface activity in airway specimens (AS). In: Proceedings of the 14th European Congress of Perinatal Medicine; 1994 June 5-8; Helsinki, Finland. 1994:Abstract no: 486. x-wiley/crsRef/3154875
39. Kari MA, Hallman M, Eronen M, Teramo K, Virtanen M, Koivisto M, et al. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomised placebo-controlled multicenter study. Pediatrics 1994;93:730-6. x-wiley/crsRef/3154876
40. Salokorpi T, Sajaniemi N, Hallback H, Kari A, Rita H, von Wendt L. Randomized study of the effect of antenatal dexamethasone on growth and development of premature children at the corrected age of 2 years. Acta Paediatrica 1997;86:294-8. x-wiley/crsRef/3154877
41. Lewis D, Brody K, Edwards M, Brouillette RM, Burlison S, London SN. Preterm premature ruptured membranes: a randomized trial of steroids after treatment with antibiotics. Obstetrics & Gynecology 1996;88(5):801-5. x-wiley/crsRef/3154882
42. Dalziel SR, Fenwick S, Cundy T, Parag V, Beck TJ, Rodgers A, et al. Peak bone mass after exposure to antenatal betamethasone and prematurity: follow-up of a randomized controlled trial. Journal of Bone & Mineral Research 2006;21(8):1175-86. x-wiley/crsRef/3154884
43. Dalziel SR, Liang A, Parag V, Rodgers A, Harding JE. Blood pressure at 6 years of age after prenatal exposure to betamethasone: follow-up results of a randomized, controlled trial. Pediatrics 2004;114:e373-e377. x-wiley/crsRef/3154885
44. Dalziel SR, Lim VK, Lambert A, McCarthy D, Parag V, Rodgers A, et al. Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial. BMJ 2005;331:665. x-wiley/crsRef/3154886
45. Dalziel SR, Lim VK, Lambert A, McCarthy D, Parag V, Rodgers A, et al. Psychological functioning and health-related quality of life in adulthood after preterm birth. Developmental Medicine and Child Neurology 2007;49(8):597-602. x-wiley/crsRef/3154887
46. Dalziel SR, Parag V, Harding JE. Blood pressure at 6 years of age following exposure to antenatal betamethasone. In: 7th Annual Congress of the Perinatal Society of Australia and New Zealand; 2003 March 9-12; Tasmania, Australia. 2003:P13. x-wiley/crsRef/3154888
47. Dalziel SR, Rea HH, Walker NK, Parag V, Mantell C, Rodgers A, et al. Long term effects of antenatal betamethasone on lung function: 30 year follow up of a randomised controlled trial. Thorax 2006;61(8):678-83. x-wiley/crsRef/3154889
48. Dalziel SR, Walker NK, Parag V, Mantell C, Rea HH, Rodgers A, et al. Cardiovascular risk factors after exposure to antenatal betamethasone: 30-year follow-up of a randomised controlled trial. Lancet 2005;365:1856-62. x-wiley/crsRef/3154890
49. Dalziel SR, Walker NK, Parag V, Mantell C, Rea HH, Rodgers A, et al. Long-term effects of antenatal exposure to betamethasone: thirty year follow-up of a randomised controlled trial [abstract]. Pediatric Research 2004;55 Suppl:101. x-wiley/crsRef/3154891
50. Dalziel SR, Walker NR, Parag V, Mantell C, Rea HH, Rodgers A, et al. Long-term effects of antenatal exposure to betamethasone: thirty year follow-up of a randomized controlled trial. In: Pediatric Academic Societies Annual Meeting; 2004 May 1-4; San Francisco, USA. 2004. x-wiley/crsRef/3154892
51. Harding JE, Pang J, Knight DB, Liggins GC. Do antenatal corticosteroids help in the setting of preterm rupture of membranes? American Journal of Obstetrics and Gynecology 2001;184:131-9. x-wiley/crsRef/3154893
52. Howie RN, Liggins GC. Clinical trial of antepartum betamethasone therapy for prevention of respiratory distress in pre-term infants. In: Anderson AB, Beard RW, Brudenell JM, Dunn PM, editors(s). Pre-term Labour. London: RCOG, 1977:281-9. x-wiley/crsRef/3154894
53. Howie RN, Liggins GC. Prevention of respiratory distress syndrome in premature infants by antepartum glucocorticoid treatment. In: Villee CA, Villee DB, Zuckerman J, editors(s). Respiratory Distress Syndrome. London & New York: Academic Press, 1973:369-80. x-wiley/crsRef/3154895
54. Howie RN, Liggins GC. The New Zealand study of antepartum glucocorticoid treatment. In: Farrell PM, editors(s). Lung Development: Biological and Clinical Perspectives, II. Academic Press: London & New York, 1982:255-65. x-wiley/crsRef/3154896
55. Howie RN. Pharmacological acceleration of lung maturation. In: Villee CA, Villee DB, Zuckerman J, editors(s). Respiratory Distress Syndrome. London & New York: Academic Press, 1986:385-96. x-wiley/crsRef/3154897
56. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515-25. x-wiley/crsRef/3154898
57. Liggins GC, Howie RN. Prevention of respiratory distress syndrome by antepartum corticosteroid therapy. In: Proceedings of Sir Joseph Barcroft Centenary Symposium, Fetal and Neonatal Physiology; 1972; UK. Cambridge University Press: UK, 1973:613-7. x-wiley/crsRef/3154899
58. Liggins GC, Howie RN. Prevention of respiratory distress syndrome by maternal steroid therapy. In: Gluck L, editors(s). Modern Perinatal Medicine. Chicago: Yearbook Publishers, 1974:415-24. x-wiley/crsRef/3154900
59. Liggins GC. Prenatal glucocorticoid treatment: prevention of respiratory distress syndrome. In: Moore TD, editors(s). Lung maturation and the prevention of hyaline membrane disease, report of 70th Ross Conference on Paediatric Research. Ross Labs, 1976:97-103. x-wiley/crsRef/3154901
60. MacArthur B, Howie RN, DeZoete A, Elkins J, Liang AY. Long term follow up of children exposed to betamethasone in utero. In: Tejani N, editors(s). Obstetrical Events and Developmental Sequelae. CRC Press, 1989:81-9. x-wiley/crsRef/3154902
61. MacArthur B, Howie RN, DeZoete A, Elkins J. Cognitive and psychosocial development of 4-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics 1981;68:638-43. x-wiley/crsRef/3154903
62. MacArthur B, Howie RN, DeZoete A, Elkins J. School progress and cognitive development of 6-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics 1982;70:99-105. x-wiley/crsRef/3154904
63. Lopez AL, Rojas RL, Rodriguez MV, Sanchez AJ. Use of corticoids in preterm pregnancy with premature rupture of membranes [Uso de los corticoides en embarazo pretermino con ruptura prematura de membranas]. Revista Colombiana de Obstetricia y Ginecologia 1989;40:147-51. x-wiley/crsRef/3154908
64. IRCT138901193666N1. Effect of antenatal betamethasone on prevention of respiratory distress syndrome among neonates with gestational age of 35-36 weeks. www.irct.ir (Date first received: 17 May 2010). x-wiley/crsRef/3154911
65. Mansouri M, Seyedolshohadaei F, Company F, Setare S, Mazhari S. Effect of antenatal betamethasone on prevention of respiratory distress syndrome among neonates with gestational age of 35-36 weeks. Journal of Gorgan University of Medical Sciences 2010;12(3):18-23. x-wiley/crsRef/3154910
66. Morales WJ, Angel JL, O'Brien WF, Knuppel RA. Use of ampicillin and corticosteroids in premature rupture of membranes: a randomized study. Obstetrics & Gynecology 1989;73:721-6. x-wiley/crsRef/3154913
67. Morrison JC, Schneider JM, Whybrew WD, Bucovaz ET. Effect of corticosteroids and fetomaternal disorders on the L:S ratio. Obstetrics & Gynecology 1980;56:583-90. x-wiley/crsRef/3154996
68. Morrison JC, Schneider JM, Whybrew WD, Bucovaz ET. Effect of corticosteroids and fetomaternal disorders on the L:S ratio. Surgery, Gynecology and Obstetrics 1981;153:464. x-wiley/crsRef/3154997
69. Morrison JC, Whybrew WD, Bucovaz ET, Scheiner JM. Injection of corticosteroids into mother to prevent neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology 1978;131:358-66. x-wiley/crsRef/3154998
70. Nelson LH, Meis PJ, Hatjis CG, Ernest JM, Dillard R, Schey HM. Premature rupture of membranes: a prospective randomized evaluation of steroids, latent phase and expectant management. Obstetrics & Gynecology 1985;66:55-8. x-wiley/crsRef/3154915
71. CTRI/2016/12/007570. Effct of antenatal corticosteroids on respiratory morbidity in late preterm newborns - a randomized controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2016/12/007570 2016. [CENTRAL: CN-01807588] x-wiley/crsRef/15907538
72. Dorairajan G, Ontela V, Vishnu B, Chinnakali P. Effect of antenatal steroids on respiratory morbidity of late preterm new-borns: a randomized controlled trial. https://epostersonline.com/rcog2018/node/58?view=true (accessed 4 September 2020). x-wiley/crsRef/15907539
73. Dorairajan G, Ontella V, Bhat V, Chinnakali P. Effect of antenatal dexamethasone on respiratory morbidity of late preterm newborns: a randomized controlled trial. BJOG: an international journal of obstetrics and gynaecology 2018;125(Suppl 1):67-8. [CENTRAL: CN-01571886] x-wiley/crsRef/15907540 [EMBASE: 621569896]
74. Ontela V, Dorairajan G, Bhat VB, Chinnakali P. Effect of antenatal steroids on respiratory morbidity of late preterm newborns: a randomized controlled trial. Journal of Tropical Pediatrics 2018;64(6):531-8. [CENTRAL: CN-01991657] x-wiley/crsRef/15907541 [EMBASE: 626300500] [PMID: 29365196]
75. Porto AM, Coutinho IC, Correia JB, Amorim MM. Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial. BMJ 2011;342:d1696. x-wiley/crsRef/3154920
76. Qublan H, Malkawi H, Hiasat M, Hindawi IM, Al-Taani MI, Abu-Khait SA, et al. The effect of antenatal corticosteroid therapy on pregnancies complicated by premature rupture of membranes. Clinical & Experimental Obstetrics & Gynecology 2001;28(3):183-6. x-wiley/crsRef/3154922
77. Schmidt PL, Sims ME, Strassner HT, Paul RH, Mueller E, McCart D. Effect of antepartum glucocorticoid administration upon neonatal respiratory distress syndrome and perinatal infection. American Journal of Obstetrics and Gynecology 1984;148:178-86. x-wiley/crsRef/3155009
78. Dessens AB, Haas HS, Koppe JG. Twenty year follow up of antenatal corticosteroid treatment. Pediatrics 2000;105(6):1325. x-wiley/crsRef/3154924
79. Dessens AB, Smolders-de Haas H, Koppe JG. Twenty year follow up in antenatally corticosteroid-treated subjects. Prenatal and Neonatal Medicine 1998;3 Suppl 1:32. x-wiley/crsRef/3154925
80. Schmand B, Neuvel J, Smolder-de Haas H, Hoeks J, Treffers PE, Koppe JG. Psychological development of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome. Pediatrics 1990;86:58-64. x-wiley/crsRef/3154926
81. Schutte MF, Koppe JG, Treffers PE, Breur W. The influence of 'treatment' in premature delivery on incidence of RDS. In: Proceedings of the 6th European Congress of Perinatal Medicine; 1978 Aug 29-Sept 1; Vienna, Austria. 1978:Abstract no: 80. x-wiley/crsRef/3154927
82. Schutte MF, Treffers PE, Koppe JG, Breur W, Filedt Kok JC. The clinical use of corticosteroids for the acceleration of fetal lung maturity [Klinische toepassing van corticosteroiden ter bevordering van de foetale long-rijpheid]. Nederlands Tijdschrift voor Geneeskunde 1979;123(11):420-7. x-wiley/crsRef/3154928
83. Schutte MF, Treffers PE, Koppe JG, Breur W. The influence of betamethasone and orciprenaline on the incidence of respiratory distress syndrome in the newborn after preterm labour. British Journal of Obstetrics and Gynaecology 1980;87:127-31. x-wiley/crsRef/3154929
84. Smolders-de Haas H, Neuvel J, Schmand B, Treffers PE, Koppe JG, Hoeks J. Physical development and medical history of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome: a 10- to 12- year follow up. Pediatrics 1990;86(1):65-70. x-wiley/crsRef/3154930
85. Shanks A, Gross G, Shim T, Allsworth J, Moga C, Sadovsky Y, et al. Antenatal steroids for enhancement of fetal lung maturity after 34 weeks: lung maturity and antenatal steroids (LUMAS) study. American Journal of Obstetrics and Gynecology 2008;199(6 Suppl 1):S58. x-wiley/crsRef/3154932
86. Shanks A, Gross G, Shim T, Allsworth J, Sadovsky Y, Bildirici I. Administration of steroids after 34 weeks of gestation enhances fetal lung maturity profiles. American Journal of Obstetrics and Gynecology 2010;203(1):47.e1-47.e5. x-wiley/crsRef/3154933
87. Silver RK, Vyskocil CR, Solomon SL, Farrell EE, MacGregor SN, Neerhof MG. Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered prior to 30 weeks of gestation. American Journal of Obstetrics and Gynecology 1995;172:254. x-wiley/crsRef/3154935
88. Silver RK, Vyskocil CR, Solomon SL, Ragin A, Neerhof MG, Farrell EE. Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered prior to 30 weeks of gestation. Obstetrics & Gynecology 1996;87:683-91. x-wiley/crsRef/3154936
89. Teramo K, Hallman M, Raivio KO. Maternal glucocorticoid in unplanned premature labor. Pediatric Research 1980;14:326-9. x-wiley/crsRef/3154940
90. ACTRN12617000476336. The WHO ACTION-I (Antenatal CorticosTeroids for Improving Outcomes in preterm Newborns) Trial: a multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low-resource countries to improve newborn outcomes. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12617000476336 (first received 2017) 2017. [CENTRAL: CN-01812305] x-wiley/crsRef/15907543
91. WHO ACTION Trials Collaborators. Antenatal dexamethasone for early preterm birth in low-resource countries. New England Journal of Medicine 2020;October 23:DOI: 10.1056/NEJMoa2022398. x-wiley/crsRef/15907544
92. WHO ACTION Trials Collaborators. The World Health Organization ACTION-I (Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns) Trial: a multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low-resource countries. Trials 2019;20(1):507. [CENTRAL: CN-02010986] x-wiley/crsRef/15907545 [EMBASE: 628924308] [PMID: 31420064]
93. Abuhamad A, Green G, Heyl P, de Veciana M. The combined use of corticosteroids and thyrotropin releasing hormone in pregnancies with preterm rupture of membranes: a randomised double blind controlled trial. American Journal of Obstetrics and Gynecology 1999;180(1 Pt 2):S96. x-wiley/crsRef/3154942
94. Althabe F, Belizan JM, Mazzoni A, Berrueta M, Hemingway-Foday J, Koso-Thomas M, et al. Antenatal corticosteroids trial in preterm births to increase neonatal survival in developing countries: study protocol. Reproductive Health 2012;9(1):22. x-wiley/crsRef/3154944
95. Althabe F, Belizan JM, McClure EM, Hemingway-Foday J, Berrueta M, Mazzoni A, et al. A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. Lancet 2015;385(9968):629-39. x-wiley/crsRef/15907546 [PMID: 25458726]
96. Goldenberg RL, Thorsten VR, Althabe F, Saleem S, Garces A, Carlo WA, et al. The global network antenatal corticosteroids trial: impact on stillbirth. Reproductive Health 2016;13(1):68. [CENTRAL: CN-01368862] x-wiley/crsRef/15907547 [EMBASE: 610555843] [PMID: 27255082]
97. NCT01084096. Trial of the use of antenatal corticosteroids in developing countries. https://clinicaltrials.gov/ct2/show/NCT01084096 (first received 2010). x-wiley/crsRef/15907548
98. Asnafei N, Pourreza R, Miri SM. Pregnancy outcome in premature delivery of between 34-37 weeks and the effects of corticosteroid on it. Journal of the Gorgan University of Medical Sciences 2004;6(2):57-60. x-wiley/crsRef/3154947
99. Butterfill AM, Harvey DR. Follow-up study of babies exposed to betamethasone before birth. Archives of Disease in Childhood 1979;54:725. x-wiley/crsRef/3154949
100. Dola C, Nageotte M, Rumney P, Towers C, Asrat T, Freeman R, et al. The effect of antenatal treatment with betamethasone and thyrotropin releasing hormone in patients with preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology 1997;176(1 Pt 2):S49. x-wiley/crsRef/3154951
101. Dude C, Dude A, Gilner J, Swamy G, Grotegut C. Predicting preterm delivery: using the MFMU BEARS trial data to optimize corticosteroid use in women at risk for preterm delivery. Reproductive Sciences (Thousand Oaks, Calif.) 2016;23(Suppl 1):188A-9A. [CENTRAL: CN-02011932] x-wiley/crsRef/15907550
102. Egerman RS, Mercer B, Doss JL, Sibai BM. A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology 1998;178(1 Pt 2):S19. x-wiley/crsRef/3154953
103. Egerman RS, Mercer BM, Doss JL, Sibai BM. A randomized, controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology 1998;179(5):1120-3. x-wiley/crsRef/3154954
104. Egerman RS, Pierce WF 4th, Andersen RN, Umstot ES, Carr TL, Sibai BM. A comparison of the bioavailability of oral and intramuscular dexamethasone in women in late pregnancy. Obstetrics & Gynecology 1997;89(2):276-80. x-wiley/crsRef/3154955
105. Egerman RS, Walker RA, Doss JL, Mercer B, Sibai BM, Andersen RN. A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology 1998;178(1 Pt 2):S182. x-wiley/crsRef/3154956
106. Egerman RS, Walker RA, Mercer BM, Doss JL, Sibai BM, Andersen RA. Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology 1998;179(5):1234-6. x-wiley/crsRef/3154957
107. Garite TJ, Freeman RK, Linzey EM, Braly PS, Dorchester WL. Prospective randomized study of corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology 1981;141:508-15. x-wiley/crsRef/3154959
108. Grgic G, Fatusic Z, Bogdanovic G. Stimulation of fetal lung maturation with dexamethasone in unexpected premature labor. Medicinski Arhiv 2003;57(5-6):291-4. x-wiley/crsRef/3154961
109. Halac E, Halac J, Begue EF, Casanas JM, Idiveri DR, Petit JF, et al. Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial. Journal of Pediatrics 1990;117:132-8. x-wiley/crsRef/3154963
110. Iams JD, Talbert ML, Barrows H, Sachs L. Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology 1985;151:32-8. x-wiley/crsRef/3154965
111. Khandelwal M, Chang E, Hansen C, Hunter K, Milcarek B. Betamethasone dosing interval -12 or 24 hours apart? American Journal of Obstetrics and Gynecology 2012;206(Suppl 1):S10-S11. x-wiley/crsRef/3154967
112. Khandelwal M, Chang E, Hansen C, Hunter K, Milcarek B. Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial. American Journal of Obstetrics and Gynecology 2012;206(3):201.e1-11. x-wiley/crsRef/3154968
113. Koivisto M, Peltoniemi OM, Saarela T, Tammela O, Jouppila P, Hallman M. Blood glucose level in preterm infants after antenatal exposure to glucocorticoid. Acta Paediatrica 2007;96(5):664-8. x-wiley/crsRef/3154970
114. Kuhn RJP, Speirs AL, Pepperell RJ, Eggers TR, Doyle LW, Hutchinson A. Betamethasone, albuterol and threatened premature delivery. Obstetrics & Gynecology 1982;60:403-8. x-wiley/crsRef/3154972
115. Kurtzman J, Garite T, Clark R, Maurel K, The OCRN. Impact of a 'rescue course' of antenatal corticosteroids (ACS): a multi-center randomized placebo controlled trial. American Journal of Obstetrics and Gynecology 2008;199(6 Suppl 1):S2. x-wiley/crsRef/3154974
116. Liu J, Wang Q, Zhao JH, Chen YH, Qin GL. The combined antenatal corticosteroids and vitamin K therapy for preventing periventricular-intraventricular hemorrhage in premature newborns less than 35 weeks gestation. Journal of Tropical Pediatrics 2006;52(5):355-9. x-wiley/crsRef/3154976
117. Magee LA, Dawes GS, Moulden M, Redman CW. A randomised controlled comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology 1997;104(11):1233-8. x-wiley/crsRef/3154978
118. Maksic H, Hadzagic-Catibusic F, Heljic S, Dizdarevic J. The effects of antenatal corticosteroid treatment on IVH-PVH of premature infants. Bosnian Journal of Basic Medical Sciences 2008;8(1):58-62. x-wiley/crsRef/3154980
119. McEvoy C, Schilling D, Clay N, Spitale P, Durand M. Neurodevelopmental outcome and growth in infants randomized to a single rescue course of antenatal steroids. In: Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting; 2011 April 30-May 3; Denver, Colorado, USA. 2011:3829.270. x-wiley/crsRef/3154982
120. McEvoy C, Schilling D, Peters D, Tillotson C, Spitale P, Wallen L, et al. Respiratory compliance in preterm infants after a single rescue course of antenatal steroids: a randomized controlled trial. American Journal of Obstetrics and Gynecology 2010;202(6):544.e1-9. x-wiley/crsRef/3154983
121. McEvoy C, Schilling D, Segel S, Spitale P, Wallen L, Bowling S, et al. Improved respiratory compliance in preterm infants after a single rescue course of antenatal steroids: a randomized trial. American Journal of Obstetrics and Gynecology 2008;199(6 Suppl 1):S228. x-wiley/crsRef/3154984
122. McEvoy C, Schilling D, Spitale P, Gravett M, Durand M. Pulmonary function and respiratory outcomes at 12-24 months in preterm infants randomized to a single rescue course of antenatal steroids. In: Pediatric Academic Societies' 2010 Annual Meeting; 2010 May 1-4; Vancouver, Canada. 2010. x-wiley/crsRef/3154985
123. McEvoy C, Schilling D, Spitale P, Wallen L, Segel S, Bowling S, et al. Improved respiratory compliance after a single rescue course of antenatal steroids: a randomized controlled trial. In: Pediatric Academic Societies Annual Meeting; 2007 May 5-8; Toronto, Canada. 2007. x-wiley/crsRef/3154987
124. McEvoy C, Schilling D, Spitale P, Wallen L, Segel S, Bowling S, et al. Improved respiratory compliance after a single rescue course of antenatal steroids: a randomized controlled trial. In: Pediatric Academic Societies Annual Meeting; 2008 May 2-6; Honolulu, Hawaii. 2008. x-wiley/crsRef/3154986
125. McEvoy C, Schilling D, Spitale P, Wallen P, Segel S, Bowling S, et al. Growth and respiratory outcomes after a single rescue course of antenatal steroids: a randomized trial. In: Pediatric Academic Societies Annual Meeting; 2009 May 2-5; Baltimore, USA. 2009. x-wiley/crsRef/3154988
126. McEvoy CT, Schilling D, Segal S, Spitale P, Wallen L, Bowling S, et al. Improved respiratory compliance in preterm infants <34 weeks after a single rescue course of antenatal steroids. American Journal of Respiratory and Critical Care Medicine 2009;179:A4127 [Poster #423]. x-wiley/crsRef/3154989
127. Minoui S, Ville Y, Senat M, Multon O, Fernandez H, Frydman R. Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labour: a randomized study. British Journal of Obstetrics and Gynaecology 1998;105:749-55. x-wiley/crsRef/3154991
128. Minoui S, Ville Y, Senat MV, Multon O, Fernandez H, Frydman R. Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor a randomized study. Prenatal and Neonatal Medicine 1996;1 Suppl 1:156. x-wiley/crsRef/3154992
129. Morales WJ, Diebel D, Lazar AJ, Zadrozny D. The effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome in preterm gestations with premature rupture of membranes. American Journal of Obstetrics and Gynecology 1986;154:591-5. x-wiley/crsRef/3154994
130. Mulder EJ, Derks JB, Visser GH. Antenatal corticosteroid therapy and fetal behaviour: a randomised evaluation of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology 1997;104(11):1239-47. x-wiley/crsRef/3155000
131. NCT02351310. Effectiveness of ACS in extreme preemies [Effects of antenatal corticosteroids in patients with early (22 - 23w6d) threatened preterm birth]. Https://clinicaltrials.gov/show/NCT02351310 (first received 2015 Jan 27). [CENTRAL: CN-01551840] x-wiley/crsRef/15907552
132. NCT04494529. Single Dose Antenatal Corticosteroids (SNACS) for women at risk of preterm birth [Single Dose Antenatal Corticosteroids (SNACS) pilot randomized control trial for women at risk of preterm birth]. https://clinicaltrials.gov/show/NCT04494529 (first received 2020 Jul 31). [CENTRAL: CN-02145746] x-wiley/crsRef/15907554
133. Papageorgiou AN, Desgranges MF, Masson M, Colle E, Shatz R, Gelfand MM. The antenatal use of betamethasone in the prevention of respiratory distress syndrome: a controlled blind study. Pediatrics 1979;63:73-9. x-wiley/crsRef/3155002
134. Romejko-Wolniewicz E, Oleszczuk L, Zareba-Szczudlik J, Czajkowski K. Dosage regimen of antenatal steroids prior to preterm delivery and effects on maternal and neonatal outcomes. Journal of Maternal-Fetal and Neonatal Medicine 2013;26(3):237-41. x-wiley/crsRef/3155004
135. Rotmensch S, Liberati M, Vishne T, Celentano C, Ben-Rafael Z, Bellati U. The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology 1998;178(1 Pt 2):S185. x-wiley/crsRef/3155006
136. Rotmensch S, Liberati M, Vishne TH, Celentano C, Ben-Rafael Z, Bellati U. The effect of betamethasone and dexamethasone on the fetal heart rate patterns and biophysical activities. A prospective randomized trial. Acta Obstetricia et Gynecologica Scandinavica 1999;78(6):493-500. x-wiley/crsRef/3155007
137. Simpson G, Harbert G. Use of beta-methasone in management of preterm gestation with premature rupture of membranes. Obstetrics & Gynecology 1985;66:168-75. x-wiley/crsRef/3155011
138. Whitt GG, Buster JE, Killam AP, Scragg WH. A comparison of two glucocorticoid regimens for acceleration of fetal lung maturation in premature labor. American Journal of Obstetrics and Gynecology 1976;124:479-82. x-wiley/crsRef/3155013
139. Botet F, Cararach V, Sentis J. Premature rupture of membranes in early pregnancy. Neonatal prognosis. Journal of Perinatal Medicine 1994;22:45-52. x-wiley/crsRef/3154837
140. Cararach V, Botet F, Sentis J, Carmona F. A multicenter, prospective randomized study in premature rupture of membranes (PROM). Maternal and perinatal complications. International Journal of Gynecology and Obstetrics 1991;36 Suppl:267. x-wiley/crsRef/3154838
141. Cararach V, Sentis J, Botet F, De Los Rios L. A multicenter, prospective randomized study in premature rupture of membranes (PROM). Respiratory and infectious complications in the newborn. In: Proceedings of the 12th European Congress of Perinatal Medicine; 1990; Lyon, France. 1990:216. x-wiley/crsRef/3154839
142. Carlan SJ, Parsons M, O'Brien WF, Krammer J. Pharmacologic pulmonary maturation in preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology 1991;164:371. x-wiley/crsRef/3154841
143. Delibas IB, Ingec M, Yapca OE. Does antenatal betamethasone have negative effects on fetal activities and hemodynamics in cases of preeclampsia without severe features? A prospective, placebo-controlled, randomized study. Journal of Maternal-fetal & Neonatal Medicine 2016 Nov;30(22):2671-8. [CENTRAL: CN-01602216] x-wiley/crsRef/15907556 [PMID: 27838943]
144. Doran TA, Swyer P, MacMurray B, Mahon W, Enhorning G, Bernstein A, et al. Results of a double blind controlled study on the use of betamethasone in the prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology 1980;136:313-20. x-wiley/crsRef/3154859
145. Goodner DM. Antenatal steroids in the treatment of respiratory distress syndrome. In: 9th World Congress of Gynecology and Obstetrics; 1979 October 26-31; Tokyo, Japan. 1979:362. x-wiley/crsRef/3154869
146. Hantoushzadeh S, Javadian P, Salmanian B, Ghazanfari T, Kermani A, Abbasalizadeh F, et al. Betamethasone effects on the endocervical inflammatory cytokines in preterm labor: a randomized clinical trial. International Immunopharmacology 2011;11(8):1116-9. x-wiley/crsRef/3154879
147. Khazardoust S, Javadian P, Salmanian B, Zandevakil F, Abbasalizadeh F, Alimohamadi S, et al. A clinical randomized trial on endocervical inflammatory cytokines and Betamethasone in prime-gravid pregnant women at risk of preterm labor. Iranian Journal of Immunology 2012;9(3):199-207. x-wiley/crsRef/3154880
148. IRCT20120918010876N3. Assessment of efficacy of antenatal betamethasone on neonatal respiratory outcome of late preterm delivery (34-37 weeks) [Assessment of efficacy of antenatal betamethasone on neonatal respiratory outcome of late preterm delivery (34-37 weeks) in singleton pregnancies]. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT20120918010876N3 2017. [CENTRAL: CN-01898197] x-wiley/crsRef/15989419
149. Mirzamoradi M, Hasani NF, Jamali R, Heidar Z, Bakhtiyari M. Evaluation of the effect of antenatal betamethasone on neonatal respiratory morbidities in late preterm deliveries (34-37 weeks). Journal of Maternal-fetal & Neonatal Medicine 2019;33(15):2533-40. [CENTRAL: CN-01787845] x-wiley/crsRef/15989420 [EMBASE: 625854285] [PMID: 30612482]
150. Parsons MT, Sobel D, Cummiskey K, Constantine L, Roitman J. Steroid, antibiotic and tocolytic vs no steroid, antibiotic and tocolytic management in patients with preterm PROM at 25-32 weeks. In: Proceedings of the 8th Annual Meeting of the Society of Perinatal Obstetricians; 1988 Feb 3-6; Las Vegas, Nevada. 1988:44. x-wiley/crsRef/3154917
151. Sobel D, Parsons M, Roitman J, McAlpine L, Cumminsky K. Antenatal antibiotics in PROM prevents congenital bacterial infection. Pediatric Research 1988;23:476A. x-wiley/crsRef/3154918
152. Taeusch HW Jr, Frigoletto F, Kitzmiller J, Avery ME, Hehre A, Fromm B, et al. Risk of respiratory distress syndrome after prenatal dexamethasone treatment. Pediatrics 1979;63:64-72. x-wiley/crsRef/3154938
153. ACTRN12617001494325. The WHO ACTION-II (Antenatal CorticosTeroids for Improving Outcomes in preterm Newborns) Trial: a multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial of antenatal corticosteroids for women at risk of imminent birth in the late preterm period in hospitals in low-resource countries to improve newborn outcomes. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12617001494325 2017. [CENTRAL: CN-01884536] x-wiley/crsRef/15907561
154. Hong S, Lee SM, Kwak DW, Lee J, Kim SY, Oh JW, et al. Effects of antenatal corticosteroids in twin neonates with late preterm birth (ACTWIN [Antenatal Corticosteroids in TWIN late preterm neonates] trial): study protocol for a randomized controlled trial. BMC Pregnancy and Childbirth 2019;19:1. [CENTRAL: CN-01939009] x-wiley/crsRef/15907563 [EMBASE: 627072824] [PMID: 30943910]
155. NCT03547791. Effects of ACS in twin with LPB: study Protocol for a RCT. https://clinicaltrials.gov/show/NCT03547791 (first received 2018 Jun 6). [CENTRAL: CN-02044889] x-wiley/crsRef/15907564
156. IRCT2014102919037N2. Evaluation of the effect of betamethasone on neonatal outcomes in pregnancies [Evaluation of the effect of betamethasone on neonatal outcomes in pregnancies in late preterm pregnancies]. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2014102919037N2 2014. [CENTRAL: CN-01877791] x-wiley/crsRef/15907566
157. NCT01206946. Efficacy of antenatal steroids in Reducing respiratory morbidities in late preterm infants [Efficacy of antenatal steroids for women at risk of late preterm delivery on neonatal respiratory morbidity]. https://clinicaltrials.gov/show/NCT01206946 (first received 2010 Sep 21). [CENTRAL: CN-01501010] x-wiley/crsRef/15907568
158. NCT03446937. Effect of antenatal corticosteroids on neonatal morbidity [Effect of antenatal corticosteroids on neonatal morbidity]. Https://clinicaltrials.gov/show/NCT03446937 (first received 2018 Feb 5). [CENTRAL: CN-01483469] x-wiley/crsRef/15907570
159. Antenatal Corticosteroids Clinical Practice Guidelines Panel. Antenatal corticosteroids given to women prior to birth to improve fetal, infant, child and adult health: Clinical Practice Guidelines. Liggins Institute, The University of Auckland, Auckland, New Zealand 2015.
160. Barker DJP. Mothers, Babies and Health in Later Life. 2nd edition. London: Churchill Livingstone, 1998.
161. Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CR. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 1993;341(8841):339-41.
162. Brownfoot FC, Gagliardi DI, Bain E, Middleton P, Crowther CA. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2013, Issue 8. Art. No: CD006764. [DOI: 10.1002/14651858.CD006764.pub3]
163. Carlisle JB. Data fabrication and other reasons for non-random sampling in 5087 randomised, controlled trial in anaesthetic and general medical journals. Anaesthesia 2017;72:944-52.
164. Chawanpaiboon S, Vogel JP, Moller A, Lumbiganon P, Petzold M, Hogan D, et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Global Health 2019;7:e37–e46.
165. Clark PM. Programming of the hypothalamo-pituitary-adrenal axis and the fetal origins of adult disease hypothesis. European Journal of Pediatrics 1998;157(1 Suppl):S7-S10.
166. Crowley P, Chalmers I, Keirse MJ. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. British Journal of Obstetrics and Gynaecology 1990;97:11-25.
167. Crowther CA, McKinlay CJD, Middleton P, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database of Systematic Reviews 2015, Issue 7. Art. No: CD003935. [DOI: 10.1002/14651858.CD003935.pub4]
168. De Angelis C, Drazen JM, Frizelle FA, et al. Clinical Trial Registration: A Statement from the International Committee of Medical Journal Editors. New England Journal of Medicine 2004;351:1250-1.
169. Deeks JJ, Higgins JP, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
170. Deshmukh M, Patole S. Antenatal corticosteroids for neonates born before 25 Weeks-A systematic review and meta-analysis. PLOS One 2017;12(9):e0176090.
171. Deshmukh M, Patole S. Antenatal corticosteroids in impending preterm deliveries before 25 weeks' gestation. Archives of Disease in Childhood. Fetal and Neonatal Edition 2018;103(2):F173-F176.
172. Dodic M, Wintour EM, Whitworth JA, Coghlan JP. Effect of steroid hormones on blood pressure. Clinical & Experimental Pharmacology & Physiology 1999;26(7):550-2.
173. Doyle LW. Victorian Infant Collaborative Study Group. Outcome at 5 years of age of children 23 to 27 weeks' gestation: refining the prognosis. Pediatrics 2001;108(1):134-41.
174. Doyle LW, Casalaz D. Victorian Infant Collaborative Study Group. Outcome at 14 years of extremely low birthweight infants: a regional study. Archives of Diseases in Childhood: Fetal and Neonatal Edition 2001;85(3):F159-F164.
175. Edwards LJ, Coulter CL, Symonds ME, McMillen IC. Prenatal undernutrition, glucocorticoids and the programming of adult hypertension. Clinical & Experimental Pharmacology & Physiology 2001;28(11):938-41.
176. Higgins JPT, Altman DG, Sterne JA (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
177. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions. 2nd edition. Chichester (UK): John Wiley & Sons, 2019.
178. Hintz SR, Van Meurs KP, Perritt R, Poole WK, Das A, Stevenson DK, et al. Neurodevelopmental outcomes of premature infants with severe respiratory failure enrolled in a randomized controlled trial of inhaled nitric oxide. Journal of Pediatrics 2007;151:e1-3.
179. Huang WL, Beazley LD, Quinlivan JA, Evans SF, Nenham JP, Dunlop SA. Effect of corticosteroids on brain growth in fetal sheep. Obstetrics & Gynecology 1999;94(2):213-8.
180. Imseis HM, Iams JD. Glucocorticoid use in patients with preterm premature rupture of fetal membranes. Seminars in Perinatology 1996;20(5):439-50.
181. Jobe AH, Wada N, Berry LM, Ikegami M, Ervin MG. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. American Journal of Obstetrics and Gynecology 1998;178(5):880-5.
182. Liggins GC. Premature delivery of foetal lambs infused with corticosteroids. Journal of Endocrinology 1969;45:515-23.
183. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50(4):515-25.
184. Liggins GC. Prenatal glucocorticoid treatment: prevention of respiratory distress syndrome. In: Moore TD, editors(s). Lung maturation and the prevention of hyaline membrane disease, Report of the Seventieth Ross Conference on Pediatric Research, Columbus, Ohio. 1976:97-103.
185. National Institutes of Health (NIH) Consensus Development Conference Statement. Effect of corticosteroids for fetal maturation on perinatal outcomes. American Journal of Obstetrics and Gynecology 1994;173:246-52.
186. Padbury JF, Ervin MG, Polk DH. Extrapulmonary effects of antenatally administered steroids. Journal of Pediatrics 1996;128(2):167-72.
187. Park CK, Isayama T, McDonald SD. Antenatal corticosteroid therapy before 24 weeks of gestation: a systematic review and meta-analysis. Obstetrics and Gynecology 2016;127(4):715-25.
188. The Cochrane Collaboration Review Manager 5 (RevMan 5). Version 5.4. The Cochrane Collaboration, 2014.
189. Rodriguez RJ, Martin RJ, Fanaroff AA. Respiratory distress syndrome and its management. In: Fanaroff AA, Martin RJ, editors(s). Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant. St. Louis: Mosby, 2002:1001-10.
190. Rohwer AC, Oladapo OT, Hofmeyr GJ. Strategies for optimising antenatal corticosteroid administration for women with anticipated preterm birth. Cochrane Database of Systematic Reviews 2020, Issue 5. Art. No: CD013633. [DOI: 10.1002/14651858.CD013633]
191. Scherer RW, Meerpohl JJ, Pfeifer N, Schmucker C, Schwarzer G, von Elm E. Full publication of results initially presented in abstracts. Cochrane Database of Systematic Reviews 2018, Issue 11. Art. No: MR000005. [DOI: 10.1002/14651858.MR000005.pub4]
192. Schwab M, Roedel M, Anwar MA, Muler T, Schubert H, Buchwalder LF, et al. Effects of betamethasone administration to the fetal sheep in late gestation on fetal cerebral blood flow. Journal of Physiology 2000;528(3):619-32.
193. Seckl JR, Cleasby M, Nyirenda MJ. Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming. Kidney International 2000;57(4):1412-7.
194. Simes RJ. Publication bias: the case for an international registry of clinical trials. Journal of Clinical Oncology 1986;4:1529-41.
195. Sotiriadis A, Makrydimas G, Papatheodorou S, Ioannidis JP, McGoldrick E. Corticosteroids for preventing neonatal respiratory morbidity after elective caesarean section at term. Cochrane Database of Systematic Reviews 2018, Issue 8. Art. No: CD006614. [DOI: 10.1002/14651858.CD006614.pub3]
196. Sterne JA, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
197. The World Medical Association. Declaration of Helsinki. https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/ 2013;Version 8.
198. Turrentine MA, Wilson PD, Wilkins IA. A retrospective analysis of the effect of antenatal steroid on the incidence of respiratory distress syndrome in preterm twin pregnancies. American Journal of Perinatology 1996;13(6):351-4.
199. Utama DP, Crowther. Transplacental versus direct fetal corticosteroid treatment for accelerating fetal lung maturation where there is a risk of preterm birth. Cochrane Database of Systematic Reviews 2018, Issue 6. Art. No: CD008981. [DOI: 10.1002/14651858.CD008981.pub3]
200. Vyas J, Kotecha S. Effects of antenatal and postnatal corticosteroids on the preterm lung. Archives of Disease in Childhood: Fetal and Neonatal Edition 1997;77(2):F147-F150.
201. Reynolds LA, Tansey EM. Prenatal corticosteroids for reducing morbidity and mortality after preterm birth. The transcript of a Witness Seminar; The Wellcome Trust Centre for History of Medicine at UCL, London 2005;25.
202. WHO. WHO recommendations on interventions to improve preterm birth outcomes: evidence base. https://www.who.int/reproductivehealth/publications/maternal_perinatal_health/preterm-birth-guideline/en/ 2015.
203. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database of Systematic Reviews 1996, Issue 1. Art. No: CD000065. [DOI: 10.1002/14651858.CD000065]
204. Crowley P, Roberts D, Dalziel SR, Shaw BNJ. Antenatal corticosteroids to accelerate fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No: CD004454. [DOI: 10.1002/14651858.CD004454]
205. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No: CD000065. [DOI: 10.1002/14651858.CD000065.pub2]
206. Roberts D, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No: CD004454. [DOI: 10.1002/14651858.CD004454.pub2]
207. Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2017, Issue 3. Art. No: CD004454. [DOI: 10.1002/14651858.CD004454.pub3]